Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.36 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.35 |
| ▸ | FDPS | P14324 | 3/20 | 0.35 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11453471 | 1.00 | OPRM1 (0.42) | OPRM1LMNADNM1TSHRTHRB | |
| SCHEMBL28289881 | 0.98 | OPRM1 (0.44) | OPRM1LMNADNM1TSHRTHRB | |
| SCHEMBL28096431 | 0.93 | THRB (0.38) | OPRM1LMNATHRB | |
| SCHEMBL4263417 | 0.90 | OPRM1 (0.46) | OPRM1LMNADNM1TSHRTHRB | |
| SCHEMBL6554404 | 0.90 | OPRM1 (0.46) | OPRM1LMNADNM1TSHRTHRB | |
| SCHEMBL23270390 | 0.90 | OPRM1 (0.46) | OPRM1LMNADNM1TSHRTHRB | |
| SCHEMBL28744275 | 0.90 | OPRM1 (0.46) | OPRM1LMNADNM1TSHRTHRB | |
| SCHEMBL19060744 | 0.90 | ALDH1A1 (0.37) | OPRM1LMNADNM1TSHRTHRB | |
| SCHEMBL4557947 | 0.90 | OPRM1 (0.46) | OPRM1LMNADNM1TSHRTHRB | |
| SCHEMBL20225052 | 0.90 | OPRM1 (0.46) | OPRM1LMNADNM1TSHRTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2575807-A1 | FORMULATION BASED ON SULPIRIDE AND A SYNERGISTIC HOMEOPATHIC COMPOSITION FOR TREATMENT OF DEPRESSIVE SYNDROME | Novak, Maja (HR) | 2013-04-10 | — | — | EP | claimed |
| WO-2011148203-A1 | FORMULATION BASED ON SULPIRIDE AND A SYNERGISTIC HOMEOPATHIC COMPOSITION FOR TREATMENT OF DEPRESSIVE SYNDROME | NOVAK MAJA (HR) | 2011-12-01 | — | — | WO | claimed |
| CN-101023123-A | Film-like polymer structure and method for producing same | OXYGENIX CO LTD (JP) | 2007-08-22 | — | — | CN | disclosed |
| EP-0955046-B1 | Amino acid derivatives as anti-inflammatory agents | AJINOMOTO KK (JP) | 2005-06-22 | — | — | EP | disclosed |
| EP-1064373-A2 | IDENTIFICATION OF FACTORS WHICH MEDIATE THE INTERACTION OF HETEROTRIMERIC G PROTEINS AND MONOMERIC G PROTEINS | ONYX PHARMACEUTICALS, INC. (US) | 2001-01-03 | — | — | EP | disclosed |
| WO-1999047557-A2 | IDENTIFICATION OF FACTORS WHICH MEDIATE THE INTERACTION OF HETEROTRIMERIC G PROTEINS AND MONOMERIC G PROTEINS | ONYX PHARMACEUTICALS, INC. (US) | 1999-09-23 | — | — | WO | disclosed |
| EP-0083619-A1 | A STABLE AQUEOUS, THERAPEUTIC INSULIN PREPARATION AND A PROCESS FOR PREPARING IT | NORDISK INSULINLABORATORIUM (DK) | 1983-07-20 | — | — | EP | disclosed |
| WO-1983000288-A1 | A STABLE AQUEOUS, THERAPEUTIC INSULIN PREPARATION AND A PROCESS FOR PREPARING IT | BALSCHMIDT, PER | 1983-02-03 | — | — | WO | disclosed |